Yew Bio-Pharm Group Inc. (YEWB) Issues Earnings Results

Yew Bio-Pharm Group Inc. (OTCMKTS:YEWB) posted its earnings results on Monday. The company reported $0.01 EPS for the quarter, Bloomberg Earnings reports. Yew Bio-Pharm Group had a return on equity of 23.77% and a net margin of 20.09%.

Shares of Yew Bio-Pharm Group (OTCMKTS:YEWB) opened at $0.22 on Tuesday. Yew Bio-Pharm Group has a 1-year low of $0.15 and a 1-year high of $0.47. The stock has a market capitalization of $11.41, a price-to-earnings ratio of 1.22 and a beta of -1.41.

COPYRIGHT VIOLATION NOTICE: This story was first posted by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this story on another site, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this story can be read at https://www.truebluetribune.com/2017/11/14/yew-bio-pharm-group-inc-yewb-issues-earnings-results.html.

About Yew Bio-Pharm Group

Yew Bio-Pharm Group, Inc is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The Company operates through five segments: traditional Chinese medicine (TCM) raw materials, which is engaged in the production and sale of raw materials used for medicinal application in the pharmaceutical industry; yew trees, which is engaged in the cultivation and sale of yew seedlings, yew trees and potted yew trees; handicrafts, which is engaged in the manufacture and sale of furniture and handicrafts made of yew timber; wood ear mushroom, which includes the sale of wood ear mushroom, and others, which includes the sale of yew candles and pine needle extracts.

Receive News & Ratings for Yew Bio-Pharm Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yew Bio-Pharm Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply